LifeSci Capital analyst Charles Zhu initiated coverage of Crescent Biopharma (CBIO) with an Outperform rating and $22 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.